{
  "nct_id": "UW 21-577",
  "age": "Adults",
  "cancer_center_accrual_goal_upper": 0,
  "data_table4": "Interventional",
  "long_title": "A randomized study of neoadjuvant chemoradiotherapy with or without intensification with the FOLFOXIRI chemo-regimen for high-risk locally advanced rectal cancer",
  "management_group_list": {
    "management_group": [
      {
        "is_primary": "Y",
        "management_group_name": "Group 1"
      }
    ]
  },
  "oncology_group_list": {
    "oncology_group": [
      {
        "group_name": "Group 1",
        "is_primary": "N"
      }
    ]
  },
  "phase": "1",
  "principal_investigator": "Dr. Aya El Helali",
  "program_area_list": {
    "program_area": [
      {
        "is_primary": "Y",
        "program_area_name": "Program 1"
      }
    ]
  },
  "protocol_id": 4,
  "protocol_no": "2025010802",
  "protocol_target_accrual": 0,
  "protocol_type": "",
  "prior_treatment_requirements": [
    "Histologically confirmed rectal adenocarcinoma (defined as either mid- or low rectal cancer that is located within 12 cm from the anal verge OR below the peritoneal reflection) that is previously untreated.",
    "Measurable disease by RECIST 1.1 criteria.",
    "High-risk rectal cancer, or rectal cancers that are considered marginally operable where there is a significant risk of ‘positive surgical margin’ (or otherwise known as ‘threatened circumferential margin’) = T3 or T4 tumor with one or more of the following features:",
    "- Tumour infiltrating perirectal fat and/or mesorectal fascia and/or vasculature",
    "- Pelvic lymph node involvement.",
    "- Absence of distant metastases."
  ],
  "short_title": "A randomized study of neoadjuvant chemoradiotherapy with or without intensification with the FOLFOXIRI chemo-regimen for high-risk locally advanced rectal cancer",
  "site_list": {
    "site": []
  },
  "sponsor_list": {
    "sponsor": []
  },
  "staff_list": {
    "protocol_staff": []
  },
  "status": "open to accrual",
  "summary": "",
  "treatment_list": {
    "step": [
      {
        "arm": [
          {
            "arm_code": "Arm A (Control)",
            "arm_internal_id": 1111,
            "arm_description": "Concurrent neoadjuvant concurrent capecitabine-radiotherapy followed by surgery and post-operative chemotherapy ",
            "arm_suspended": "N"
          },
          {
            "arm_code": "Arm B (Experimental)",
            "arm_internal_id": 2222,
            "arm_description": "Neoadjuvant FOLFOXIRI x 4 cycles then concurrent capecitabineradiotherapy, surgery and post-operative chemotherapy",
            "arm_suspended": "N"
          }
        ],
        "step_code": "1",
        "step_type": "Registration",
        "step_internal_id": 1111,
        "match": [
          {
            "and": [
              {
                "clinical": {
                  "oncotree_primary_diagnosis": "Rectal Adenocarcinoma"
                }
              }
            ]
          }
        ]
      }
    ]
  }
}